Pridopidine for treating Huntington's disease [ID6525]
Awaiting development
Reference number: GID-TA11637
Expected publication date: TBC
Following an update from the company responsible for pridopidine, NICE will not be progressing with the scoping exercise at this time.
The consultation on the draft scope will now close and the workshop arranged for Wednesday 25 June 2025 has been cancelled. Please accept our apologies for any inconvenience.
As this evaluation has been referred to NICE, we will continue dialogue with the company and will update interested parties if the situation changes